文档介绍：海峡药学 年 第 卷 第 期
2021 33 7
minuria identifies individuals at increased renal risk 〔 J〕 . J Am Soc 289:H2649-H2656.
Nephrol，2009，20（4):852-862. 〔11〕de Zeeuw D，Remuzzi G，Parving HH，et al. ，Proteinuria，a target for
〔4〕 Hemmelgarn BR，Manns BJ，Lloyd A，et al. Relation between kidney renoprotection in patients with type 2 diabetic nephropathy: lessons
function，proteinuria， and adverse outcomes 〔 J 〕 . JAMA， 2010， 303 from RENAAL〔J〕. Kidney Int，2004，65（6):2309-2320.
（5):423-429. 〔12〕Schmitz A，Vaeth M，Mogensen CE. Systolic blood pressure relates to
〔5〕 Marti F，Vollenweider P，Marques-Vidal PM，et al. Hyperhomocysteinemia the rate of progression of albuminuria in NIDDM〔 J〕 . Diabetologia，
is independently associated with albuminuria in the population-based 1994，37（12):1251-1258.
CoLaus study〔J〕. BMC Public Health，2011，11:733. 〔13〕Vermeulen EG，Rauwerda JA，van den Berg M，et al. Homocysteine-
〔6〕 Jager A，Kostense PJ，Nijpels G，et al. Serum homocysteine levels are lowering treatment with folic acid plus vitamin B6 lowers urinary al-
associated with the development of